Taken together, these data support our hypothesis that upregulated TNFSF15 in APRC4 and NDUFV1 knockdown GBM cells plays an immune-stimulatory role in enhancing CAR T cell efficacy. The gene discussed is TNFSF15; the disease is glioblastoma.